Carmen Burkhardt

594 total citations
13 papers, 468 citations indexed

About

Carmen Burkhardt is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carmen Burkhardt has authored 13 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carmen Burkhardt's work include Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Carmen Burkhardt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Carmen Burkhardt collaborates with scholars based in Austria, Germany and France. Carmen Burkhardt's co-authors include Thomas Ciossek, Thomas M. Maier, H. Wieland, Thomas Beckers, Karl Sanders, Martin Zacharias, Uwe Reusch, Eugene A. Zhukovsky, Melvyn Little and Stefan Knackmuss and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Carmen Burkhardt

11 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Burkhardt Austria	6	310	179	115	79	38	13	468
Tristan Gallenne Netherlands	8	458 1.5×	206 1.2×	89 0.8×	89 1.1×	18 0.5×	14	633
Alexis S. Lopez United States	6	226 0.7×	170 0.9×	86 0.7×	27 0.3×	30 0.8×	8	495
Sharon Yang United States	9	221 0.7×	129 0.7×	126 1.1×	62 0.8×	22 0.6×	10	433
Andrey V. Reshetnyak United States	10	218 0.7×	127 0.7×	69 0.6×	59 0.7×	29 0.8×	14	407
Brian W. Raden United States	6	217 0.7×	142 0.8×	97 0.8×	80 1.0×	14 0.4×	6	384
P D Ariniello United States	10	252 0.8×	136 0.8×	175 1.5×	122 1.5×	12 0.3×	10	464
Hong‐Jun Liao United States	8	308 1.0×	162 0.9×	50 0.4×	87 1.1×	14 0.4×	11	485
Melinda D. Willard United States	15	306 1.0×	144 0.8×	35 0.3×	33 0.4×	37 1.0×	27	478
Laurence Stechly France	7	297 1.0×	77 0.4×	210 1.8×	26 0.3×	23 0.6×	7	390
Samuel Hong United States	14	430 1.4×	109 0.6×	65 0.6×	49 0.6×	25 0.7×	19	593

Countries citing papers authored by Carmen Burkhardt

Since Specialization

Citations

This map shows the geographic impact of Carmen Burkhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Burkhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Burkhardt more than expected).

Fields of papers citing papers by Carmen Burkhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Burkhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Burkhardt. The network helps show where Carmen Burkhardt may publish in the future.

Co-authorship network of co-authors of Carmen Burkhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Burkhardt. A scholar is included among the top collaborators of Carmen Burkhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Burkhardt. Carmen Burkhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Reusch, Uwe, Carmen Burkhardt, Ivica Fucek, et al.. (2014). A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30⁺tumor cells. mAbs. 6(3). 727–738. 135 indexed citations

Zhukovsky, Eugene A., Stefan Knackmuss, Uwe Reusch, et al.. (2014). Preclinical development, primary and secondary phrmacodynamics, of the CD19/CD3 Tandab (AFM11).. Journal of Clinical Oncology. 32(15_suppl). e19546–e19546. 1 indexed citations

Zhukovsky, Eugene A., Uwe Reusch, Carmen Burkhardt, et al.. (2013). A CD19/CD3 Bispecific Tandab, AFM11, Recruits T Cells To Potently and Safely Kill CD19+ Tumor Cells. Blood. 122(21). 4405–4405. 1 indexed citations

Zhukovsky, Eugene A., Uwe Reusch, Carmen Burkhardt, et al.. (2013). AFM11, a CD19/CD3 bispecific tandab, to facilitate T-cell-mediated killing of CD19+ cells.. Journal of Clinical Oncology. 31(15_suppl). 3068–3068. 2 indexed citations

Reusch, Uwe, Carmen Burkhardt, Stefan Knackmuss, et al.. (2012). Abstract 4624: High affinity CD3 RECRUIT-TandAbs for T cell-mediated lysis of malignant CD19+ B cells. Cancer Research. 72(8_Supplement). 4624–4624. 1 indexed citations

Knackmuss, Stefan, Uwe Reusch, Carmen Burkhardt, et al.. (2012). Preclinical development of an anti-CD30/anti-CD16A bispecific tetravalent TandAb antibody for the treatment of Hodgkin lymphoma.. Journal of Clinical Oncology. 30(15_suppl). e18532–e18532. 1 indexed citations

Knackmuss, Stefan, Uwe Reusch, Carmen Burkhardt, et al.. (2012). Abstract 3522: Preclinical development of an anti-CD30/anti-CD16A bispecific tetravalent TandAb antibody for the treatment of Hodgkin lymphoma. Cancer Research. 72(8_Supplement). 3522–3522. 5 indexed citations

Zhukovsky, Eugene A., Uwe Reusch, Carmen Burkhardt, et al.. (2012). High affinity CD3 RECRUIT TandAb for T cell-mediated lysis of CD19⁺ tumor B cells.. Journal of Clinical Oncology. 30(15_suppl). 8059–8059. 1 indexed citations

Dehmel, Florian, Thomas Ciossek, Thomas M. Maier, et al.. (2008). Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles. Journal of Medicinal Chemistry. 51(13). 3985–4001. 33 indexed citations

10.

Beckers, Thomas, Carmen Burkhardt, H. Wieland, et al.. (2007). Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. International Journal of Cancer. 121(5). 1138–1148. 157 indexed citations

11.

Burkhardt, Carmen, Diana Imhof, J Ringel, et al.. (2004). Effective Dephosphorylation of Src Substrates by SHP-1. Journal of Biological Chemistry. 279(12). 11375–11383. 78 indexed citations

12.

Zhang, Suisheng, Katrin Buder, Carmen Burkhardt, et al.. (2002). Nuclear DNA Helicase II/RNA Helicase A Binds to Filamentous Actin. Journal of Biological Chemistry. 277(1). 843–853. 36 indexed citations

13.

Burkhardt, Carmen & Martin Zacharias. (2001). Modelling ion binding to AA platform motifs in RNA: a continuum solvent study including conformational adaptation. Nucleic Acids Research. 29(19). 3910–3918. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact